Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival-Reference-Cited by-同舟云学术

Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

Published:2012-01 Issue:1 Volume:77 Page:130-134
ISSN:1878-8750
Container-title:World Neurosurgery
language:en
Short-container-title:World Neurosurgery

Author:

Burkhardt Jan-Karl,Riina Howard,Shin Benjamin J.,Christos Paul,Kesavabhotla Kartik,Hofstetter Christoph P.,Tsiouris Apostolos John,Boockvar John A.

Funder

Clinical Translational Science Center

Publisher

Elsevier BV

Subject

Neurology (clinical),Surgery

Reference20 articles.

1. Bevacizumab in recurrent malignant glioma;Abrey;Curr Neurol Neurosci Rep,2008

2. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma;Boockvar;J Neurosurg,2011

3. A perivascular niche for brain tumor stem cells;Calabrese;Cancer Cell,2007

4. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials;Carson;J Clin Oncol,2007

5. The perivascular niche microenvironment in brain tumor progression;Charles;Cell Cycle,2010

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Super selective intra-arterial cerebral infusion (SSIACI) for newly diagnosed and recurrent glioblastoma;Journal of the Pakistan Medical Association;2024-06-28

2. Endovascular Applications for the Management of High-Grade Gliomas in the Modern Era;Cancers;2024-04-22

3. Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial;Nature Communications;2024-01-12

4. Breaking Barriers in Neuro-Oncology: A Scoping Literature Review on Invasive and Non-Invasive Techniques for Blood–Brain Barrier Disruption;Cancers;2024-01-04

5. Novel Approaches to Bypassing the Blood-Brain Barrier for Drug Delivery to Brain Tumors;Interdisciplinary Cancer Research;2024